Masashi Murata

Learn More
A victim detection system is proposed for rescue operations in urban disaster areas. This system consists of autonomous mobile robots and a stationary monitor station connected by a wireless ad hoc network with an active network operation. Robots are instructed to detect victims in a disaster area and send the information to the monitor station through the(More)
Although topical TLR7 therapies such as imiquimod have proved successful in the treatment of dermatological malignancy, systemic delivery may be required for optimal immunotherapy of nondermatological tumors. We report that intravenous delivery of the novel small molecule TLR7 agonist, DSR-6434, leads to the induction of type 1 interferon and activation of(More)
This paper investigates QoS routing in an ad hoc network applied to a multi-robot network system named the " victim detection system " proposed for detecting victims in urban disaster areas. For the purpose to secure the surviv-ability of victims, a modified frame structure is examined in this paper based on the already proposed method: synchronized QoS(More)
In this paper, we describe an experimental speech translation system utilizing small, PC-based hardware with multi-modal user interface. Two major problems for people using an automatic speech translation device are speech recognition errors and language translation errors. In this paper we focus on developing techniques to overcome these problems. The(More)
Strategies to augment anti-cancer immune responses have recently demonstrated therapeutic utility. To date clinical success has been achieved through targeting co-inhibitory checkpoints such as CTLA-4, PD-1, and PD-L1. However, approaches that target co-activatory pathways are also being actively being developed. Here we report that the novel TLR7-selective(More)
TLR7 agonists are being progressed as potential immu-notherapeutics for the treatment of cancer. TLR7 agon-ism is believed to trigger a plasmacytoid dendritic cell driven immune response which drives anti-tumor efficacy. In addition to modulation of the immune system, TLR7 may be involved in tumor progression due to expression of TLR7 by tumor cells(More)